Heart failure and circulatory devices

Driveline thinner and more flexible: the possible key to achieving the lowest possible infection risk?

A retrospective, multicentre study from 9 centres in China evaluating 181 patients treated with a novel durable ventricular assist device featuring a fully magnetically levitated centrifugal pump and an ultrathin, highly flexible driveline designed to reduce local trauma at the exit site and, consequently, infection.

Management of post-infarction ventricular septal defect: is early microaxial support the new turning point?

This single-center retrospective observational study evaluates the impact of an initial strategy based on microaxial flow support with Impella® devices, comparing percutaneous models (Impella 2.5®/CP®) with high-flow devices surgically implanted via the axillary approach (Impella 5.0®/5.5®), and their effect on clinical stabilization, access to delayed surgery, and early survival in patients with post-infarction ventricular septal defect (VSD).

Ventricular support in children with congenital heart disease: time to join “ACTION” promptly!

This study analyzes data from the ACTION registry to assess whether morbidity and mortality after ventricular assist device (VAD) implantation differ between children with and without congenital heart disease (CHD), and whether outcomes among those with CHD vary according to anatomy (single- vs. biventricular).